Front. Oncol.Frontiers in OncologyFront. Oncol.2234-943XFrontiers Media S.A.10.3389/fonc.2024.1505996OncologyCorrectionCorrigendum: Prognostic significance of FDG PET/CT in esophageal squamous cell carcinoma in the era of the 8th AJCC/UICC staging systemLeeHyunjong1LeeKyung Soo2MinYang Won3KimHong Kwan4ZoJae Ill4ShimYoung Mog3ChoiJoon Young1*1Department of Nuclear Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea2Department of Radiology, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea3Division of Gastroenterology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea4Department of Thoracic Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea
Approved by: Frontiers Editorial Office, Frontiers Media SA, Lausanne, Switzerland
*Correspondence: Joon Young Choi, jynm.choi@samsung.com
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
A Corrigendum on Prognostic Significance of FDG PET/CT in esophageal squamous cell carcinoma in the era of the 8th AJCC/UICC staging system By Lee H, Lee KS, Min YW, Kim HK, Zo JI, Shim YM and Choi JY (2022). Front. Oncol. 12:861867. doi: 10.3389/fonc.2022.861867esophageal cancersquamous cell carcinomaFDG PET/CTprognosis8th AJCC staging systemsection-in-acceptanceThoracic Oncology
In the published article, there was an error in Figure 2 as published. The figure legends of all four panels was reversed. The corrected Figure 2 and its caption appear below.
Survival curves according to SUVmax UVmax with median cutoff was a significant prognostic factor in both disease-free survival (A) and overall survival (B). SUVmax with the best cutoff to discriminate prognosis of overall survival most accurately in all patients showed the same results in both disease-free survival (C) and overall survival (D).
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.